STERIALS

The Company will research, develop, manufacture and market, both domestically and internationally, proprietary portable organ perfusion systems that transport organs in an environment similar to that found in the donor's body. By storing and transporting lungs, hearts and livers while they remain perfused with oxygenated blood, the Company has the potential to improve clinical outcomes and significantly improve the utilization of donor organs for transplant.